Noncanonical PRC1.1 targets BTG2 to retain cyclin gene expression and cell growth in neuroblastoma
Abstract Cancer cells exploit epigenetic modifications and post-transcriptional regulations to form oncogenic gene expression networks. However, how these machineries collaboratively orchestrate malignancy remains elusive. One of aberrant epigenetic pathways in cancer is Polycomb repressive complex...
Saved in:
| Main Authors: | Shunpei Satoh, Mariko Hasegawa, Ryu Okada, Masayuki Haruta, Hisanori Takenobu, Miki Ohira, Takehiko Kamijo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-06-01
|
| Series: | Oncogenesis |
| Online Access: | https://doi.org/10.1038/s41389-025-00561-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted disruption of PRC1.1 complex enhances bone remodeling
by: Liangyu Xing, et al.
Published: (2025-05-01) -
The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
by: Rachel Doidge, et al.
Published: (2012-01-01) -
The PRC’s UNSC Policy Evolution
by: A. M. Galimullin
Published: (2021-08-01) -
Enhancement of quantum sensing by noncanonical effects
by: Shi-Xuan Li, et al.
Published: (2025-06-01) -
Pharmacological inhibition of PLK1/PRC1 triggers mitotic catastrophe and sensitizes lung cancers to chemotherapy
by: Pingping Li, et al.
Published: (2025-05-01)